Found: 9
Select item for more details and to access through your institution.
On-demand male contraception via acute inhibition of soluble adenylyl cyclase.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36119-6
- By:
- Publication type:
- Article
Soluble adenylyl cyclase inhibition prevents human sperm functions essential for fertilization.
- Published in:
- Molecular Human Reproduction, 2021, v. 27, n. 9, p. 1, doi. 10.1093/molehr/gaab054
- By:
- Publication type:
- Article
Corrigendum: Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential.
- Published in:
- Frontiers in Physiology, 2023, v. 14, p. 1, doi. 10.3389/fphys.2023.1163389
- By:
- Publication type:
- Article
Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 01, doi. 10.3389/fphys.2022.1013845
- By:
- Publication type:
- Article
Front Cover: Development of a New Structural Class of Broadly Acting HCV Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876 (ChemMedChem 17/2017).
- Published in:
- ChemMedChem, 2017, v. 12, n. 17, p. 1418, doi. 10.1002/cmdc.201700490
- By:
- Publication type:
- Article
Development of a New Structural Class of Broadly Acting HCV Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876.
- Published in:
- ChemMedChem, 2017, v. 12, n. 17, p. 1436, doi. 10.1002/cmdc.201700228
- By:
- Publication type:
- Article
Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity.
- Published in:
- ChemMedChem, 2013, v. 8, n. 12, p. 1930, doi. 10.1002/cmdc.201300343
- By:
- Publication type:
- Article
Discovery of a Pharmacologically Active Antagonist of the Two-Pore-Domain Potassium Channel K<sub>2P</sub>9.1 (TASK-3).
- Published in:
- ChemMedChem, 2012, v. 7, n. 1, p. 123, doi. 10.1002/cmdc.201100351
- By:
- Publication type:
- Article
Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis.
- Published in:
- Journal of Antibiotics, 2017, v. 70, n. 5, p. 671, doi. 10.1038/ja.2016.165
- By:
- Publication type:
- Article